Msefsl

CLOSE X

Risk Disclosures on Derivatives

>9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
>On an average, loss makers registered net trading loss close to ₹ 50,000.
>Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
>Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.

GLAXOSMITHKLINE CONSUMER HEALTHCARE LTD. - (AMALGAMATED)

NSE : NABSE : 500676ISIN CODE : INE264A01014Industry : Consumer FoodHouse : Glaxosmithkline - MNC

BSE10753.650 (0 %)

PREV CLOSE ( ) 10753.65

OPEN PRICE ( ) 10500.00

BID PRICE (QTY) 0.00 (0)

OFFER PRICE (QTY) 0.00 (0)

VOLUME 2533

TODAY'S LOW / HIGH ( )10394.05 10845.75

52 WK LOW / HIGH ( ) 10394.0510845.75

NSE

This Company is not listed in NSE

BSE NSE

1D 1M 3M 1Y 3Y 5Y

STOCK SUMMARY

Incorporation Year : 30-10 1958

Management Info

P Dwarakanath - Chairman Navneet Saluja - Managing Director

Registered Office

Address Patiala Road,,,
Nabha,
Punjab-147201

Phone

Email investor.2.co@gsk.com.

Website www.gsk-ch.in

Registrars Details

K FIN Technologies Ltd.-(Karvy Fintech Pvt Ltd.)

Karvy Selenium Tower B, Plot 31-32,Gachibowli,Financial District,Nanakramguda,Hyderabad

Listing : BSE, NSE

NEWS

15Dec Glaxosmithkline Pharmaceuticals inform
Pursuant to Regulation 39 and other application regulations of SEBI (Lis..

19Mar GlaxosmithKline Consumer Healthcare in
Pursuant to Regulation 39 of SEBI (Listing Obligations and Disclosure Re..

13Mar GlaxosmithKline Consumer Healthcare in
Pursuant to Regulation 39 of SEBI (Listing Obligations and Disclosure Re..

29Jan GlaxoSmithKline Consumer Healthcare in
Pursuant to Regulation 39 of SEBI (Listing Obligations and Disclosure Re..

07Nov GlaxoSmithKline Consumer Healthcare in
GlaxoSmithKline Consumer Healthcare has informed that pursuant to Regula..

Financials

Rs. in Millions

	QTR Dec 19	ANNUAL 19
Net Profit	2766.3	9828
Gross Profit	3674.6	15122.9
Operating Profit	3881.2	15735.7
Net Sales	11588.6	47820.1

ROLLING FORWARD P/E (EOD)

EVENT CALENDAR

peer group

Tasty Bite Eatables (BSE) 11777.05 (0.97%)	M.Cap ( in Cr)3021.99
Mrs.Bectors Food (BSE) 1232.70 (6.86%)	M.Cap ( in Cr)7250.43
Varun Beverages (BSE) 1457.80 (1.17%)	M.Cap ( in Cr)189427.07
IB Infotech (BSE) 132.85 (9.79%)	M.Cap ( in Cr)17.01
Marico (BSE) 517.70 (1.53%)	M.Cap ( in Cr)66995.65

Shareholding Pattern

	PROMOTERS	72.46%
	NON-INSTITUTION	16.4%
	MUTUAL FUNDS/UTI	3.68%
	FI/BANKS/INSURANCE	2.88%
	GOVERNMENT	0%
	FII	0%

Mf Holdings

Scheme Name	Hold(%)
No Data Found

Risk Disclosures on Derivatives

Smart Quotes

GLAXOSMITHKLINE CONSUMER HEALTHCARE LTD. - (AMALGAMATED)